Comparison of IPSS and flow cytometric scores in MDS patients
IPSS score . | N . | Flow score, median, % (range) . | Myeloblasts by flow, median, % (range) . |
|---|---|---|---|
| 0 (low risk) | 13 | 1 (0-4) | 2.5 (0.2-7.0) |
| 0.5-1.0 (int-1 risk) | 52 | 2 (0-6) | 2.9 (0.0-11.0) |
| 1.5-2.0 (int-2 risk) | 31 | 4 (0-7) | 6 (0.8-39.0) |
| 2.5 or more (high risk) | 17 | 6 (3-9) | 11 (0.8-58.0) |
IPSS score . | N . | Flow score, median, % (range) . | Myeloblasts by flow, median, % (range) . |
|---|---|---|---|
| 0 (low risk) | 13 | 1 (0-4) | 2.5 (0.2-7.0) |
| 0.5-1.0 (int-1 risk) | 52 | 2 (0-6) | 2.9 (0.0-11.0) |
| 1.5-2.0 (int-2 risk) | 31 | 4 (0-7) | 6 (0.8-39.0) |
| 2.5 or more (high risk) | 17 | 6 (3-9) | 11 (0.8-58.0) |